BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32436207)

  • 1. [Neuropsychological profile in patients with myotonic dystrophy type 1: a four-year follow-up study].
    Díaz-Leiva J; Cabada-Giadás T; Seijas-Gómez R; Jericó-Pascual I; López-Sala P; Iridoy-Zulet M
    Rev Neurol; 2020 Jun; 70(11):406-412. PubMed ID: 32436207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A descriptive study of the neuropsychological and psychopathological profile in patients with type 1 myotonic dystrophy].
    Seijas-Gomez R; Basterra-Jimenez I; Luna-Lario P; Tirapu-Ustarroz J; Cabada-Giadas T; Iridoy-Zulet M; Jerico-Pascual I; Gargallo-Vaamonde Á; Lopez-Goni JJ
    Rev Neurol; 2015 Dec; 61(12):529-35. PubMed ID: 26662870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive assessment in patients with myotonic dystrophy type 2.
    Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
    Gutiérrez Gutiérrez G; Díaz-Manera J; Almendrote M; Azriel S; Eulalio Bárcena J; Cabezudo García P; Camacho Salas A; Casanova Rodríguez C; Cobo AM; Díaz Guardiola P; Fernández-Torrón R; Gallano Petit MP; García Pavía P; Gómez Gallego M; Gutiérrez Martínez AJ; Jericó I; Kapetanovic García S; López de Munaín Arregui A; Martorell L; Morís de la Tassa G; Moreno Zabaleta R; Muñoz-Blanco JL; Olivar Roldán J; Pascual Pascual SI; Peinado Peinado R; Pérez H; Poza Aldea JJ; Rabasa M; Ramos A; Rosado Bartolomé A; Rubio Pérez MÁ; Urtizberea JA; Zapata-Wainberg G; Gutiérrez-Rivas E
    Med Clin (Barc); 2019 Jul; 153(2):82.e1-82.e17. PubMed ID: 30685181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
    Labayru G; Aliri J; Zulaica M; López de Munain A; Sistiaga A
    J Neuropsychol; 2020 Mar; 14(1):121-134. PubMed ID: 31407859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
    Gutiérrez Gutiérrez G; Díaz-Manera J; Almendrote M; Azriel S; Eulalio Bárcena J; Cabezudo García P; Camacho Salas A; Casanova Rodríguez C; Cobo AM; Díaz Guardiola P; Fernández-Torrón R; Gallano Petit MP; García Pavía P; Gómez Gallego M; Gutiérrez Martínez AJ; Jericó I; Kapetanovic García S; López de Munaín Arregui A; Martorell L; Morís de la Tassa G; Moreno Zabaleta R; Muñoz-Blanco JL; Olivar Roldán J; Pascual Pascual SI; Peinado Peinado R; Pérez H; Poza Aldea JJ; Rabasa M; Ramos A; Rosado Bartolomé A; Rubio Pérez MÁ; Urtizberea JA; Zapata-Wainberg G; Gutiérrez-Rivas E
    Neurologia (Engl Ed); 2020 Apr; 35(3):185-206. PubMed ID: 31003788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
    Winblad S; Samuelsson L; Lindberg C; Meola G
    Eur J Neurol; 2016 Sep; 23(9):1471-6. PubMed ID: 27323306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
    Gallais B; Gagnon C; Mathieu J; Richer L
    Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-year follow-up study of an atypical case of myotonic dystrophy.
    Macniven JA; Graham NL; Davies RR; Wilson BA
    Brain Inj; 2005 Dec; 19(14):1213-21. PubMed ID: 16286337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological profile in myotonic dystrophy.
    Censori B; Danni M; Del Pesce M; Provinciali L
    J Neurol; 1990 Jul; 237(4):251-6. PubMed ID: 2391548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.
    Antonini G; Soscia F; Giubilei F; De Carolis A; Gragnani F; Morino S; Ruberto A; Tatarelli R
    J Rehabil Med; 2006 May; 38(3):181-5. PubMed ID: 16702085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
    Theodosiou T; Christidi F; Xirou S; Bede P; Karavasilis E; Papadopoulos C; Kourtesis P; Pantoleon V; Kararizou E; Papadimas G; Zalonis I
    Cogn Behav Neurol; 2021 Mar; 34(1):1-10. PubMed ID: 33652465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
    Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
    Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward understanding cognitive impairment in patients with myotonic dystrophy type 1.
    Zalonis I; Bonakis A; Christidi F; Vagiakis E; Papageorgiou SG; Kalfakis N; Manta P; Vassilopoulos D
    Arch Clin Neuropsychol; 2010 Jun; 25(4):303-13. PubMed ID: 20237049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment in myotonic dystrophy type 1 (Steinert's disease)].
    Rosado Bartolomé A; Puertas Martín V; Domínguez González C; Ramos Miranda M
    Semergen; 2022 Apr; 48(3):208-213. PubMed ID: 35292189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive phenotype of childhood myotonic dystrophy type 1: A multicenter pooled analysis.
    Sweere DJJ; Moelands SVL; Klinkenberg S; Leenen L; Hendriksen JGM; Braakman HMH
    Muscle Nerve; 2023 Jul; 68(1):57-64. PubMed ID: 37129457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis.
    Okkersen K; Buskes M; Groenewoud J; Kessels RPC; Knoop H; van Engelen B; Raaphorst J
    Cortex; 2017 Oct; 95():143-155. PubMed ID: 28892766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.